Timeline
More in Pharma
Poolbeg activates first site for POLB 001 TOPICAL trial
"We believe POLB 001 has the potential to transform the cancer immunotherapy field through the prevention of CRS," said Jeremy Skillington, Chief Executive Officer
Search for companies, sectors, market news and more
Navigate
Browse by Sector
Market reports
Daily reports
Sector reports
Energy & Resources
Financials
Technology
Healthcare
Topics
Top Stocks
Industrials
Consumer
Top Stocks